RU2351606C1 - Uniformly tritiated triterpene glycosides of holothurians cucumaria - Google Patents
Uniformly tritiated triterpene glycosides of holothurians cucumaria Download PDFInfo
- Publication number
- RU2351606C1 RU2351606C1 RU2007136802/04A RU2007136802A RU2351606C1 RU 2351606 C1 RU2351606 C1 RU 2351606C1 RU 2007136802/04 A RU2007136802/04 A RU 2007136802/04A RU 2007136802 A RU2007136802 A RU 2007136802A RU 2351606 C1 RU2351606 C1 RU 2351606C1
- Authority
- RU
- Russia
- Prior art keywords
- tritiated
- cucumaria
- holothurians
- triterpene glycosides
- uniformly
- Prior art date
Links
- 241001137883 Cucumaria Species 0.000 title claims abstract description 4
- 150000007949 saponins Chemical class 0.000 title claims description 12
- 229910052722 tritium Inorganic materials 0.000 claims description 9
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000003708 ampul Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Abstract
Description
Изобретение относится к области органической химии и может найти применение в аналитической химии, биоорганической химии, биохимии и прикладной медицине.The invention relates to the field of organic chemistry and can find application in analytical chemistry, bioorganic chemistry, biochemistry and applied medicine.
При изучении физиологически активных соединений могут быть необходимы их меченые аналоги.When studying physiologically active compounds, their labeled analogues may be necessary.
Известны тритерпеновые гликозиды голотурий Cucumaria формулы:Known triterpene glycosides of holothurium Cucumaria of the formula:
Данные тритерпеновые гликозиды обладают ярко выраженным иммуномодуляторным действием (Sedov A.M.; Apollonin, A.V.; Sevastyanova E.К. Stimulation of mice non specific antibacterial resistance to conditionally pathogenic gram-negative microorganisms. Antibiot. Khimioter. 1990, 35 (1), 23-26) [I].These triterpene glycosides have a pronounced immunomodulatory effect (Sedov AM; Apollonin, AV; Sevastyanova E.K. Stimulation of mice non specific antibacterial resistance to conditionally pathogenic gram-negative microorganisms. Antibiot. Khimioter. 1990, 35 (1), 23-26 ) [I].
Однако эти меченные тритием тритерпеновые гликозиды не описаны.However, these tritium-labeled triterpene glycosides are not described.
Техническим результатом, достигаемым настоящим изобретением, является расширение ассортимента меченых аналогов физиологически активных соединений.The technical result achieved by the present invention is to expand the range of labeled analogues of physiologically active compounds.
Достигается указанный технический результат получением высокомеченных тритием тритерпеновых гликозидов формулы:This technical result is achieved by obtaining highly tritiated triterpene glycosides of the formula:
Известно, что замена атомов соединений на их меченые аналоги не приводит к изменению каких-либо свойств исходного соединения (Evans Е.А. - Tritium and its compounds London Butterworths, 1974, p.48).It is known that replacing the atoms of compounds with their labeled analogues does not lead to a change in any properties of the starting compound (Evans E.A. - Tritium and its compounds London Butterworths, 1974, p. 48).
Ниже приведены примеры реализации изобретения.The following are examples of the implementation of the invention.
Пример 1Example 1
В ампулу помещали 70 мг 5% Pd/C и добавляли к нему раствор 10 мг ненасыщенного тритерпенового гликозида в 0.1 мл диметилсульфоксида. Содержимое ампулы замораживали жидким азотом, вакуумировали до давления 0.1 Па, заполняли газообразным тритием до давления 400 гПа и выдерживали при температуре 25°С в течение 6 ч. Затем содержимое ампулы вновь замораживали жидким азотом и вакуумировали до давления 0.1 Па для удаления газообразного трития. В ампулу добавили 4 мл воды и содержимое ампулы перемешивали на магнитной мешалке 10 мин. Водный раствор фильтровали, вещество с катализатора экстрагировали метанолом (5×2 мл). Фильтраты объединяли и упаривали на роторном испарителе. После выделения ненасыщенного тритерпенового гликозида методом ВЭЖХ (колонка Kromasil 100С18, 7 мкм, 10×8 мм, система: смесь метанола с 5 мМ Н3PO4 3:1, скорость потока элюента - 2 мл/мин, время удерживания - 3.70 мин) выход меченого препарата - 26%, молярная радиоактивность - 22 Ки/ммоль, радиохимическая чистота 96-98%.70 mg of 5% Pd / C was placed in an ampoule, and a solution of 10 mg of unsaturated triterpene glycoside in 0.1 ml of dimethyl sulfoxide was added to it. The contents of the ampoule were frozen with liquid nitrogen, evacuated to a pressure of 0.1 Pa, filled with gaseous tritium to a pressure of 400 hPa and kept at 25 ° C for 6 h. Then, the contents of the ampoule were again frozen with liquid nitrogen and evacuated to a pressure of 0.1 Pa to remove tritium gas. 4 ml of water was added to the ampoule and the contents of the ampoule were stirred on a magnetic stirrer for 10 minutes. The aqueous solution was filtered, the substance from the catalyst was extracted with methanol (5 × 2 ml). The filtrates were combined and evaporated on a rotary evaporator. After isolation of the unsaturated triterpene glycoside by HPLC (Kromasil 100C18 column, 7 μm, 10 × 8 mm, system: methanol mixture with 5 mM H 3 PO 4 3: 1, eluent flow rate - 2 ml / min, retention time - 3.70 min) the yield of the labeled drug was 26%, the molar radioactivity was 22 Ci / mmol, and the radiochemical purity was 96-98%.
Пример 2Example 2
В ампулу помещали 1 мг меченого тритием ненасыщенного тритерпенового гликозида (22 Ки/ммоль), 40 мг 5% Pd/C и 2 мл воды. Содержимое ампулы замораживали жидким азотом, вакуумировали до давления 0.1 Па, заполняли газообразным тритием до давления 400 гПа, нагревали до 25°С и перемешивали на магнитной мешалке в течение 15 ч. Затем содержимое ампулы вновь замораживали жидким азотом и вакуумировали до давления 0.1 Па для удаления газообразного трития. Водный раствор фильтровали, вещество с катализатора экстрагировали метанолом (5×2 мл). Фильтраты объединяли и упаривали на роторном испарителе. Насыщенный тритерпеновый гликозид выделяли методом ВЭЖХ, как описано в примере 1 (время удерживания - 5.23 мин).1 mg of tritium-labeled unsaturated triterpene glycoside (22 Ci / mmol), 40 mg of 5% Pd / C and 2 ml of water were placed in the ampoule. The contents of the ampoule were frozen with liquid nitrogen, evacuated to a pressure of 0.1 Pa, filled with gaseous tritium to a pressure of 400 hPa, heated to 25 ° C and stirred on a magnetic stirrer for 15 hours. Then, the contents of the ampoule were again frozen with liquid nitrogen and vacuum to a pressure of 0.1 Pa to remove gaseous tritium. The aqueous solution was filtered, the substance from the catalyst was extracted with methanol (5 × 2 ml). The filtrates were combined and evaporated on a rotary evaporator. Saturated triterpene glycoside was isolated by HPLC as described in Example 1 (retention time 5.23 min).
Выход меченого насыщенного тритерпенового гликозида достигал 12%, молярная радиоактивность - 71 Ки/ммоль. После первой очистки выделено 6.5 мКи меченого препарата с радиохимической чистотой 93-95%, после второй очистки получено 4.5 мКи насыщенного тритерпенового гликозида с радиохимической чистотой 96-98%.The yield of labeled saturated triterpene glycoside reached 12%, molar radioactivity - 71 Ci / mmol. After the first purification, 6.5 mCi of the labeled preparation with a radiochemical purity of 93-95% was isolated; after the second purification, 4.5 mCi of saturated triterpene glycoside with a radiochemical purity of 96-98% was obtained.
Таким образом получены новые высокомеченные тритием физиологически активные соединения.Thus, new physiologically active compounds highly labeled with tritium were obtained.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2007136802/04A RU2351606C1 (en) | 2007-10-04 | 2007-10-04 | Uniformly tritiated triterpene glycosides of holothurians cucumaria |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2007136802/04A RU2351606C1 (en) | 2007-10-04 | 2007-10-04 | Uniformly tritiated triterpene glycosides of holothurians cucumaria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2351606C1 true RU2351606C1 (en) | 2009-04-10 |
Family
ID=41014893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007136802/04A RU2351606C1 (en) | 2007-10-04 | 2007-10-04 | Uniformly tritiated triterpene glycosides of holothurians cucumaria |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2351606C1 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2271820C1 (en) * | 2004-07-02 | 2006-03-20 | Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН | Immunomodulating agent and pharmaceutical composition based on the same |
-
2007
- 2007-10-04 RU RU2007136802/04A patent/RU2351606C1/en not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2271820C1 (en) * | 2004-07-02 | 2006-03-20 | Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН | Immunomodulating agent and pharmaceutical composition based on the same |
Non-Patent Citations (1)
| Title |
|---|
| АВИЛОВ С.А. Хим. прир. соед. 1984, №6, с.799-808. SEDOV A.M., APOLLONIN et al Antibiot. Khimioter. 1990, 35(1), 23-26. * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2533710T3 (en) | Process for the preparation of morpholinyl anthracycline derivatives | |
| Bara et al. | Talaromins A and B, new cyclic peptides from the endophytic fungus Talaromyces wortmannii | |
| Mishra et al. | First noscapine glycoconjugates inspired by click chemistry | |
| US9233318B2 (en) | Purification method of azacyclohexapeptide or its salt | |
| Zampella et al. | Homophymines B–E and A1–E1, a family of bioactive cyclodepsipeptides from the sponge Homophymia sp. | |
| EP2943503A1 (en) | Polymyxins, compositions, methods of making and methods of use | |
| RU2351606C1 (en) | Uniformly tritiated triterpene glycosides of holothurians cucumaria | |
| CN106946957B (en) | The preparation method of Arbekacin intermediate | |
| CN107325159A (en) | One class vancomycin derivatives, its preparation method, pharmaceutical composition and purposes | |
| RU2398770C1 (en) | Tritium-labelled 3-[5-(2-flurophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid | |
| Kuczynska et al. | Synthesis of lupane saponins from acetylated glycosyl donors by acetonitrile directed glycosylation | |
| RU2499786C1 (en) | UNIFORMLY LABELLED (3aS, 5S, 6R, 7aR, 7bS, 9aS, 10R, 12aS, 12bS)-10-[(2S, 3R, 4R, 5S)-3,4-DIHYDROXY-5,6-DIMETHYL-2-HEPTANYL]-5,6-DIHYDROXY-7a,9a-DIMETHYLHEXADECANE HYDRO-3H-BENZO [c]INDENO [5,4-e]OXEPIN-3-ONE TRIMER | |
| RU2189971C1 (en) | Highly labeled with tritium | |
| Masood-ur-Rahman et al. | Synthesis and antimicrobial activity of triazolyl analogs of diosgenin | |
| Tang et al. | Identification of scutellarein metabolites in rat using ultra performance liquid chromatography/quadrupole-time-of-flight mass spectrometry | |
| RU2368613C1 (en) | Uniformly tritium-labeled 4,4-difluoro-n-{(1s)-3-[3-(3-isopropyl-5-methyl-4h-1,2,4-triazol-4-yl)-8-azabicyclo[3,2,1]oct-8-yl]-1-phenylpropyl}cyclohexane carbodiimide | |
| RU2323224C1 (en) | Tritium uniformly labeled 3h-amphotericin b | |
| RU2318806C1 (en) | Tritium uniformly labeled [3h]-trans-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxo-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenic acid | |
| RU2305103C1 (en) | Uniformly tritium-labeled [3h]-14-hydroxydaunomycin of adriamycinone | |
| RU2233285C1 (en) | Highly tritium labeled [3h]-rapamycin | |
| RU2326889C1 (en) | α-HEDERIN UNIFORMLY MARKED WITH TRITIUM | |
| RU2268256C1 (en) | Tritium high-labeled [3h]-(e)-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-noneneamide | |
| RU2668982C1 (en) | Tritiated 3,7-bis(2,3-dihydro-1-benzofuran-5-ylcarbonyl)-1,5-dimethyl-3,7-diazabicyclo[3.3.1]nonan-9-one | |
| CN106117244A (en) | The process for purification of Cefditoren pivoxil Cephalosporins | |
| Wang et al. | Isolation and structure characterization of related impurities in etimicin intermediate P1 by LC/ESI–MSn and NMR |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20131005 |